8 reports

  • 7.1.5 TABLE FOR LICENSING DEALS WITH DISCLOSED DEAL VALUE
  • 7.2.5 TABLE FOR CO-DEVELOPMENT DEALS WITH DISCLOSED DEAL VALUE

Kite Pharma Announces Positive Topline KTE-C## Data from ZUMA-## Business Wire.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • NewLink Genetics Corporation
  • THE 34 COMPANIES PIPELINE CANCER VACCINES COVERED IN THE REPORTS ARE AS FOLLOWS

ISA Pharmaceuticals ##.

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Vaccine
  • NewLink Genetics Corporation
  • IDO inhibitors pipeline candidates by companies
  • ACTIVE COMPANIES: CATEGORY AND PARAMETERS

You can easily book an appointment with one online.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • NewLink Genetics Corporation
  • PANCREATIC CANCER THERAPEUTICS, GLOBAL, DEVELOPMENTAL PIPELINE, PHASE III, 2015
  • 8.3 References

Celgene obtains an exclusive option on one of OncoMed Pharma' s most advanced clinical candidates, demcizumab.

  • Pancreatic Cancer
  • Pharmaceutical
  • World
  • Forecast
  • NewLink Genetics Corporation

Pancreatic cancer

4546 5000 3864

Pharmaceuticals Policy and Law, ##, ##-##.

  • Obesity
  • Pancreatic Cancer
  • Pharmaceutical
  • Therapy
  • NewLink Genetics Corporation
  • IMMUNE CHECKPOINT INHIBITORS: DISTRIBUTION BY DRUG DEVELOPERS
  • IMMUNE CHECKPOINT INHIBITORS: DISTRIBUTION BY DRUG DEVELOPERS

Roche NA NA AstraZeneca ## I NCT## Recruiting Kyowa Hakko Kirin Pharma, Inc.

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Market Size
  • NewLink Genetics Corporation
  • NEWLINK GENETICS CORP, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2012 TO YTD 2018
  • NEWLINK GENETICS CORP, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2012 TO YTD 2018

NewLink Genetics Corp (NLNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Pharmaceutical
  • United States
  • World
  • Company Financials
  • NewLink Genetics Corporation
  • NEWLINK GENETICS CORPORATION, KEY FACTS
  • NEWLINK GENETICS CORPORATION - RESEARCH AND DEVELOPMENT OVERVIEW

May ##, 2012 D-##MT Updated To NLG## Apr ##, 2012 NewLink Genetics Corporation announced that the United States Patent & Trademark Office (USPTO) has allowed broad claims to oral pharmaceutical compositions comprising ##-methyl-D-tryptophan (D-##MT) (US Serial No. ##/ ##, ##

  • Pharmaceutical
  • Vaccine
  • United States
  • Company Operations
  • NewLink Genetics Corporation